Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) [Phase 3]
Phase 3 trial evaluating Ultrase MT12 in young children with cystic fibrosis and pancreatic insufficiency has completed, and results have be…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: A Study in Adult and Pediatric Patients With Cystic Fibrosis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating an experimental therapy for cystic fibrosis in adult and pediatric patients, sponsored by Me…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT) [Phase 3]
A Phase 3 trial of Ivacaftor in cystic fibrosis patients carrying the R117H CFTR mutation (KONDUCT) has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis [Phase 4]
This Phase 4 clinical trial update presents long-term safety data for tobramycin inhalation powder in people with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Study to Investigate Lung Deposition of Radiolabelled OligoG [Phase 2]
A Phase 2 study evaluating the lung deposition of radiolabelled OligoG in cystic fibrosis patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease [Phase 2]
A Phase 2 study evaluating INS37217 inhalation solution for mild to moderate cystic fibrosis lung disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment [Phase 2]
A Phase 2 trial evaluating KB001-A on time-to-need for antibiotic treatment in cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Glutamine Supplementation in Cystic Fibrosis [Phase 2]
Phase 2 clinical trial evaluating glutamine supplementation in cystic fibrosis has completed, with investigation of effects on immune functi…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis [Phase 1, Phase 2]
A cross-over study of OligoG in subjects with cystic fibrosis has completed Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: A Safety and Tolerability Study of Denufosol in 2-4 Year Olds [Phase 2]
A phase 2 safety and tolerability study of denufosol in 2- to 4-year-old children with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients
This completed clinical trial investigated distinguishing Staphylococcus aureus infection from colonization in patients with cystic fibrosis…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
A prospective cohort study evaluating whether sputum purulence predicts cystic fibrosis exacerbations. The study has completed recruitment a…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis [Phase 3]
A Phase 3 trial evaluating nasal inhalation of Pulmozyme (dornase alfa) in cystic fibrosis patients with chronic rhinosinusitis has complete…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization [Phase 2]
Phase 2 clinical trial evaluating nasal inhalation of tobramycin in patients with cystic fibrosis and Pseudomonas aeruginosa colonization; t…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis [Phase 3]
Phase 3 clinical trial assessing nasal inhalation of dornase alfa (Pulmozyme) in cystic fibrosis patients with chronic rhinosinusitis has co…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Action of Epigenetic Modifiers in Cystic Fibrosis Treatment [NA]
The document reports on a completed clinical trial assessing the effects of epigenetic modifiers for cystic fibrosis treatment.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Sweat Evaporimeter Measurement [NA]
Clinical trial update reports completion of a University of Colorado, Denver study on cystic fibrosis using sweat evaporimeter measurements.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation
This clinical trial update reports findings on biomarkers of exacerbation in cystic fibrosis from a completed study led by the University of…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis [NA]
A clinical trial assessing sodium chloride 6.0% sino-nasal inhalation in patients with cystic fibrosis and chronic rhinosinusitis has comple…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation [Phase 1]
This Clinical Trial Update reports safety and pharmacokinetic results from a Phase 1 study of N6022 in cystic fibrosis patients homozygous f…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) Patients [NA]
A completed clinical trial evaluated cholecalciferol (vitamin D3) for treating vitamin D deficiency in adults with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis
This clinical trial update reports completion of a study assessing how chronic rhinosinusitis affects health-related quality of life in adul…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency [Phase 2]
Phase 2 trial results evaluating Bucelipase alfa (BSSL) in cystic fibrosis patients with exocrine pancreatic insufficiency. Results were pos…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis [Phase 2]
Phase 2 clinical trial evaluating a nasally delivered Pulmozyme (dornase alfa) for sinusitis in cystic fibrosis; the study completed and res…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT
A completed clinical trial update comparing laboratory blood glucose measurements with the HemoCue Glucose 201 RT in individuals with cystic…